Cart
sales@molnova.com
GS967
CAS No. 1262618-39-2
GS967( GS967 | GS-967 | GS 967 | GS458967 )
Catalog No. M11095 CAS No. 1262618-39-2
GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 154 | In Stock |
|
| 50MG | 277 | In Stock |
|
| 100MG | 485 | In Stock |
|
| 200MG | 703 | In Stock |
|
| 500MG | 1088 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGS967
-
NoteResearch use only, not for human use.
-
Brief DescriptionGS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).
-
DescriptionGS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa); inhibits ATX-II-induced late I(Na) in ventricular myocytes and isolated hearts with IC(50) values of 0.13 and 0.21 μM, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsGS967 | GS-967 | GS 967 | GS458967
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
Recptorlate?INa?,isolated hearts| late?INa?,ventricular myocytes
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number1262618-39-2
-
Formula Weight347.22
-
Molecular FormulaC14H7F6N3O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESFC(C1=NN=C2C=CC(C3=CC=C(OC(F)(F)F)C=C3)=CN21)(F)F
-
Chemical Name6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)(1,2,4)triazolo(4,3-a)pyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Belardinelli L, et al. J Pharmacol Exp Ther. 2013 Jan;344(1):23-32.
molnova catalog
related products
-
NaV1.7 inhibitor-1
NaV1.7 inhibitor-1, an efficacious inhibitor of voltage-gated sodium channel (NaV) 1.7 (IC50 of 0.6 nM for hNaV1.7).
-
Ranolazine dihydroch...
An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
-
Bupivacaine hydrochl...
Bupivacaine hydrochloride monohydrate is a potent NMDA receptor inhibitor of sodium, L-calcium, and potassium channels.
